Amgen (AMGN) Total Non-Current Liabilities (2009 - 2026)

Amgen (AMGN) has reported Total Non-Current Liabilities for 18 consecutive years, with $80.6 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Non-Current Liabilities changed 0.49% year-over-year to $80.6 billion; the TTM figure through Mar 2026 stood at $80.6 billion (changed 0.49% YoY), while the FY2025 annual figure was $79.6 billion, down 4.86% from the prior year.
• Total Non-Current Liabilities came in at $80.6 billion for Q1 2026 at Amgen, up from $79.6 billion in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $87.9 billion in Q1 2024, with the low at $51.3 billion in Q2 2022.
• Average Total Non-Current Liabilities over 5 years is $76.0 billion, with a median of $81.0 billion recorded in 2025.
• Across the five-year window, Total Non-Current Liabilities soared 62.35% in 2023 and fell 7.94% in 2025, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $61.2 billion in 2022, then soared by 40.94% to $86.2 billion in 2023, then slipped by 3.05% to $83.6 billion in 2024, then slipped by 4.86% to $79.6 billion in 2025, then grew by 1.26% to $80.6 billion in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $80.6 billion, $79.6 billion, and $78.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.